These phenotypes are often seen in chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia (JMML) and more rarely acute myeloid leukemia (AML) patients harboring KRAS mutations. This evidence concerns the gene KRAS and juvenile myelomonocytic leukemia.